These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The efficacy of adenovirus-mediated gene therapy of ovarian cancer is enhanced by using the cytomegalovirus promoter. Tong X; Engehausen DG; Freund CT; Agoulnik I; Guo Z; Oehler MK; Kim TE; Hasenburg A; Contant CF; Woo SL; Kieback DG Anticancer Res; 1998; 18(2A):719-25. PubMed ID: 9615711 [TBL] [Abstract][Full Text] [Related]
4. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters. Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218 [TBL] [Abstract][Full Text] [Related]
5. [Animal experiment on gene therapy of ovarian cancer by adenovirus-mediated thymidine kinase gene transduction and ganciclovir administration in vivo]. Tong X; Sei W; Gu M Zhonghua Fu Chan Ke Za Zhi; 1997 Dec; 32(12):712-4. PubMed ID: 9772431 [TBL] [Abstract][Full Text] [Related]
7. Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer. Tang Q; Zhang D; Wan M; Jin L Cancer Biother Radiopharm; 2007 Dec; 22(6):755-61. PubMed ID: 18158766 [TBL] [Abstract][Full Text] [Related]
8. Imaging adenoviral-mediated herpes virus thymidine kinase gene transfer and expression in vivo. Tjuvajev JG; Chen SH; Joshi A; Joshi R; Guo ZS; Balatoni J; Ballon D; Koutcher J; Finn R; Woo SL; Blasberg RG Cancer Res; 1999 Oct; 59(20):5186-93. PubMed ID: 10537296 [TBL] [Abstract][Full Text] [Related]
9. In vivo gene therapy of ovarian cancer by adenovirus-mediated thymidine kinase gene transduction and ganciclovir administration. Tong XW; Block A; Chen SH; Contant CF; Agoulnik I; Blankenburg K; Kaufman RH; Woo SL; Kieback DG Gynecol Oncol; 1996 May; 61(2):175-9. PubMed ID: 8626129 [TBL] [Abstract][Full Text] [Related]